Jiangxi Institute of Biological Products Inc. (HKG:6915)

Hong Kong · Delayed Price · Currency is HKD

10.74

+0.45 (4.37%)

At close: Oct 7, 2026

HKG:6915 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.00	0.00	0.00	0.06
Debt / EBITDA Ratio	0.01	0.01	0.01	0.35
Debt / FCF Ratio	0.03	0.04	0.01	0.55
Net Debt / Equity Ratio	-0.49	-0.15	-0.14	-0.10
Net Debt / EBITDA Ratio	-4.25	-0.65	-0.60	-0.63
Net Debt / FCF Ratio	-14.16	-3.52	-0.65	-0.97
Asset Turnover	-	0.45	0.45	-
Inventory Turnover	-	0.90	1.15	-
Quick Ratio	9.28	2.95	1.52	0.96
Current Ratio	10.69	4.20	2.30	1.39
Return on Equity (ROE)	-	21.04%	19.64%	-
Return on Assets (ROA)	-	12.08%	10.42%	-
Return on Invested Capital (ROIC)	17.75%	22.78%	20.12%	12.91%
Return on Capital Employed (ROCE)	10.30%	20.30%	20.40%	13.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Payout Ratio	-	-	54.32%	155.30%